These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 1354613)
1. Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype. Fuerstenberg S; Leitner I; Schroeder C; Schwarz H; Vennström B; Beug H EMBO J; 1992 Sep; 11(9):3355-65. PubMed ID: 1354613 [TBL] [Abstract][Full Text] [Related]
2. v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene. Zenke M; Kahn P; Disela C; Vennström B; Leutz A; Keegan K; Hayman MJ; Choi HR; Yew N; Engel JD Cell; 1988 Jan; 52(1):107-19. PubMed ID: 2830979 [TBL] [Abstract][Full Text] [Related]
3. v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII. Disela C; Glineur C; Bugge T; Sap J; Stengl G; Dodgson J; Stunnenberg H; Beug H; Zenke M Genes Dev; 1991 Nov; 5(11):2033-47. PubMed ID: 1682217 [TBL] [Abstract][Full Text] [Related]
4. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the v-erbA protein is required for its function as an oncogene. Glineur C; Zenke M; Beug H; Ghysdael J Genes Dev; 1990 Oct; 4(10):1663-76. PubMed ID: 1979040 [TBL] [Abstract][Full Text] [Related]
6. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors. Schroeder C; Raynoschek C; Fuhrmann U; Damm K; Vennström B; Beug H Oncogene; 1990 Oct; 5(10):1445-53. PubMed ID: 1979159 [TBL] [Abstract][Full Text] [Related]
7. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter. Rascle A; Ghysdael J; Samarut J Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146 [TBL] [Abstract][Full Text] [Related]
8. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Zenke M; Muñoz A; Sap J; Vennström B; Beug H Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036 [TBL] [Abstract][Full Text] [Related]
9. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression. Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136 [TBL] [Abstract][Full Text] [Related]
10. Defective v-erbB genes can be complemented by v-erbA in erythroblast and fibroblast transformation. Jansson M; Beug H; Gray C; Graf T; Vennström B Oncogene; 1987 May; 1(2):167-73. PubMed ID: 2830578 [TBL] [Abstract][Full Text] [Related]
11. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha. Damm K; Evans RM Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566 [TBL] [Abstract][Full Text] [Related]
12. The v-erbA oncoprotein of the AEV transforming retrovirus binds to the promoter region of the erythroid-specific band 3 gene. Ingvarsson S; Vennström B Ann N Y Acad Sci; 1994 Jun; 724():426-9. PubMed ID: 7913305 [No Abstract] [Full Text] [Related]
13. The v-ski oncogene cooperates with the v-sea oncogene in erythroid transformation by blocking erythroid differentiation. Larsen J; Beug H; Hayman MJ Oncogene; 1992 Oct; 7(10):1903-11. PubMed ID: 1408132 [TBL] [Abstract][Full Text] [Related]
14. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation? Ghysdael J; Beug H Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction. Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411 [TBL] [Abstract][Full Text] [Related]
16. Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR. Barettino D; Bugge TH; Bartunek P; Vivanco Ruiz MD; Sonntag-Buck V; Beug H; Zenke M; Stunnenberg HG EMBO J; 1993 Apr; 12(4):1343-54. PubMed ID: 8096810 [TBL] [Abstract][Full Text] [Related]
17. v-erbA acts on retinoic acid receptors in immature avian erythroid cells. Sande S; Sharif M; Chen H; Privalsky M J Virol; 1993 Feb; 67(2):1067-74. PubMed ID: 8093487 [TBL] [Abstract][Full Text] [Related]
18. Impaired ferritin mRNA translation in primary erythroid progenitors: shift to iron-dependent regulation by the v-ErbA oncoprotein. Mikulits W; Schranzhofer M; Bauer A; Dolznig H; Lobmayr L; Infante AA; Beug H; Müllner EW Blood; 1999 Dec; 94(12):4321-32. PubMed ID: 10590077 [TBL] [Abstract][Full Text] [Related]
19. A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes. Damm K; Beug H; Graf T; Vennström B EMBO J; 1987 Feb; 6(2):375-82. PubMed ID: 2884103 [TBL] [Abstract][Full Text] [Related]
20. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action. Schroeder C; Gibson L; Zenke M; Beug H Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]